Recall of Burlington Medical Leg Wraps Due to Attenuation Degradation
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Burlington Medical, LLC is recalling 103 units of their Leg Wraps because of potential attenuation degradation over time, which could decrease the product's lifespan.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 14, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Burlington Medical, LLC is voluntarily recalling their Leg Wraps due to a potential for attenuation degradation over time, which decreases the lifespan of the product.
Which Products Are Affected
The recall affects 103 units of Burlington Medical Leg Wraps. All serial numbers manufactured with Xenolite 800 attenuation material from January 16, 2025, to January 21, 2026, are included. The specific models are:
- Model Number: R8LGW1; UDI-DI: 00840331272079 (Product Code: LGW8SET-R8LGW1)
- Model Number: R8LGW2; UDI-DI: 00840331272086 (Product Code: LGW8SET-R8LGW2)
- Model Number: R8LGW3; UDI-DI: 00840331272055 (Product Code: LGW8SET-R8LGW3)
- Model Number: S8LGW1; UDI-DI: 00840331272116 (Product Code: LGW8SET-S8LGW1)
- Model Number: S8LGW2; UDI-DI: 00840331272123 (Product Code: LGW8SET-S8LGW2)
- Model Number: S8LGW3; UDI-DI: 00840331272093 (Product Code: LGW8SET-S8LGW3)
- Model Number: S8LGW4; UDI-DI: 00840331272109 (Product Code: LGW8SET-S8LGW4)
- Model Number: U8LGW1; UDI-DI: 00840331272154 (Product Code: LGW8SET-U8LGW1)
- Model Number: U8LGW2; UDI-DI: 00840331272161 (Product Code: LGW8SET-U8LGW2)
- Model Number: U8LGW4; UDI-DI: 00840331272147 (Product Code: LGW8SET-U8LGW4) The distribution was nationwide in the US and international to countries including Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam.
What You Should Do
The firm has initiated this recall voluntarily and notified via letter. Consumers should contact Burlington Medical, LLC at 3 Elmhurst St, Suite 112, Newport News, VA 23603-1137 for instructions on the recall, including returns or refunds.
Why This Matters
This recall ensures the safety and effectiveness of medical devices, as degradation could impact their performance over time.
Source
FDA recall announcement, recall number Z-1761-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,901 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 14, 2026.
Frequently Asked Questions
Common questions about this FDA recall.